Lifetime risk of renal replacement therapy in Europe: A population-based study using data from the ERA-EDTA Registry

Nephrology Dialysis Transplantation

Volumn 32, Issue 2, 2017, Pages 348-355

  Van Den Brand, Jan A J G ^a   Pippias, Maria ^b   Stel, Vianda S ^b   Caskey, Fergus J ^c,d   Collart, Frederic ^e   Finne, Partik ^f,g   Heaf, James ^h   Jais, Jean Philippe ⁱ   Kramar, Reinhard ^j   Massy, Ziad A ^k,l   De Meester, Johan ^m   Traynor, Jamie P ⁿ   Reisæter, Anna Varberg ^o   Wetzels, Jack F M ^a   Jager, Kitty J ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^f UNIVERSITY OF HELSINKI   (Finland)

^g Finnish Registry for Kidney Diseases   (Finland)

^h ZEALAND UNIVERSITY HOSPITAL   (Denmark)

ⁱ UNIVERSITÉ PARIS DESCARTES   (France)

^j Austrian Dialysis and Transplantation Registry Klinikum Kreuzschwestern   (Austria)

^k HÔPITAL AMBROISE PARÉ   (France)

^l CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^m Dutch Speaking Belgian Renal Registry ^*  (Belgium)

ⁿ Scottish Renal Registry   (United Kingdom)

^o OSLO UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

End stage renal disease; Lifetime risk; Living kidney donor; Mortality; Renal replacement therapy

Indexed keywords

ADULT; AGE; ARTICLE; CONTROLLED STUDY; END STAGE RENAL DISEASE; EUROPE; EUROPEAN; FEMALE; GENDER; HUMAN; INCIDENCE; KIDNEY DONOR; LIFETIME RISK; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; POPULATION RESEARCH; REGISTER; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SEX DIFFERENCE; UNITED STATES; AGED; ETHNIC GROUP; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ETHNIC GROUPS; EUROPE; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; REGISTRIES; RENAL REPLACEMENT THERAPY; YOUNG ADULT;

EID: 85016018894     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfw392     Document Type: Article

References (22)

1. Muzaale AD,Massie AB,WangMC et al. Risk of end-stage renal disease following live kidney donation. JAMA 2014; 311: 579-586
2. GramsME, Sang Y, Levey AS et al. Kidney-failure risk projection for the living kidney-donor candidate. N Engl JMed 2015; 374: 411-421
3. Turin TC, Tonelli M, Manns BJ et al. Lifetime risk of ESRD. J Am Soc Nephrol 2012; 23: 1569-1578
4. ERA-EDTA Registry. ERA-EDTA Registry Annual Report 2012. Amsterdam, The Netherlands: Academic Medical Center, Department of Medical Informatics, 2014
5. United States Renal Data System. 2015 USRDS annual data report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2015
6. Vandenbroucke JP, Pearce N. Incidence rates in dynamic populations. Int J Epidemiol 2012; 41: 1472-1479
7. Hallan SI, Matsushita K, Sang Y et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 2012; 308: 2349-2360
8. Verduijn M, Grootendorst DC, Dekker FWet al. The analysis of competing events like cause-specific mortality-beware of the Kaplan-Meier method. Nephrol Dial Transplant 2011; 26: 56-61
9. Gooley TA, LeisenringW, Crowley J et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18: 695-706
10. Choudhury JB. Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data. Stat Med 2002; 21: 1129-1144
11. Beiser A, D'Agostino RB, Seshadri S et al. Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The practical incidence estimators (PIE) macro. Stat Med 2000; 19: 1495-1522
12. Grams ME, Chow EK, Segev DL et al. Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis 2013; 62: 245-252
13. World Health Organization. Global Health Observatory - Blood Pressure. http://www.who.int/gho/ncd/risk-factors/blood-pressure-prevalence/en/ (15 August 2015, date last accessed)
14. World Health Organization. Noncommunicable Diseases Country Profiles 2011. http://www.who.int/nmh/publications/ncd-profiles2011/en/ (15 August 2015, date last accessed)
15. Danaei G, Finucane MM, Lu Y et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2-7 million participants. Lancet 2011; 378: 31-40
16. Caskey FJ, Kramer A, Elliott RF et al. Global variation in renal replacement therapy for end-stage renal disease. Nephrol Dial Transplant 2011; 26: 2604-2610
17. O'Hare AM, Choi AI, Bertenthal D et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 2007; 18: 2758-2765
18. Nitsch D, Grams M, Sang Y et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a metaanalysis. BMJ 2013; 346: f324
19. Couchoud C, Guihenneuc C, Bayer F et al. Medical practice patterns and socio-economic factors may explain geographical variation of end-stage renal disease incidence. Nephrol Dial Transplant 2012; 27: 2312-2322
20. Castledine CI, Gilg JA, Rogers C et al. How much of the regional variation in RRT incidence rates within the UK is explained by the health needs of the general population? Nephrol Dial Transplant 2012; 27: 3943-3950
21. van de Luijtgaarden MW, Noordzij M, van Biesen W et al. Conservative care in Europe-nephrologists' experience with the decision not to start renal replacement therapy. Nephrol Dial Transplant 2013; 28: 2604-2612
22. Mjien G, Hallan S, Hartmann A et al. Long-term risks for kidney donors. Kidney Int 2014; 86: 162-167